Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Trichloroethylene Exposure Linked to Parkinson’s Disease Risk: Study The U.S. Environmental Protection Agency banned TCE in December 2024, after finding it posed a risk of cancer and other health complications. October 8, 2025 Martha Garcia Add Your Comments New research indicates people exposed to the cancer-causing industrial chemical, trichloroethylene (TCE), also face a 10% greater risk of experiencing neurological damage. TCE is a chemical solvent that has been commercially produced since the 1920s and widely used for metal degreasing, dry cleaning and decaffeinating coffee. It has also been commonly found in products like cleaning wipes, spray adhesives, carpet cleaners and spot removers. However, prior research shows that water contaminated with TCE can leach into surrounding residential neighborhoods, where it has the ability to sicken residents with a number of adverse health conditions, including Parkinson’s disease, a neurological disorder that disrupts a person’s movement, balance and coordination. Symptoms of Parkinson’s disease include tremors, slowed movement, stiffness, balance issues, difficulty walking, slurred speech, memory loss and reduced cognitive function, which often worsens with time. There is no cure for Parkinson’s disease, although its symptoms can be treated with some medications. Camp Lejeune TCE Contamination In 2023, a study conducted by researchers from the University of California, San Francisco found rates of Parkinson’s disease were much higher among military veterans who were exposed to TCE-contaminated water at Camp Lejeune, a U.S. Marine Corps training base in North Carolina. Veterans had a 70% higher risk of Parkinson’s disease if they were exposed to the water than those who were not. U.S. Centers for Disease Control and Prevention (CDC) research also indicated vets stationed at Camp Lejeune in the 50s and 60s who were exposed to tainted water had a 20% higher risk of developing certain blood and organ cancers. It was eventually determined that more than one million veterans and family members who worked or lived at Camp Lejeune were exposed to contaminated water. As a result, hundreds of thousands of Camp Lejeune lawsuits and administrative claims have been filed after those who served, lived or worked on the base developed cancer, Parkinson’s disease and other health side effects. Following the introduction of this litigation, the U.S. Environmental Protection Agency (EPA) banned TCE in December 2024. However, there are still many contaminated industrial sites across the country. Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More Stay Up-to-Date About Camp Lejeune Lawsuits AboutLawsuits.com sends a weekly digest email with information about recalls, lawsuits and warnings that may impact your family, which will include any new Camp Lejeune lawsuit updates or developments. "*" indicates required fields Email* SIGN ME UP Δ Learn More TCE Parkinson’s Disease Links According to findings published in the journal Neurology on October 1, contaminated industrial facilities where TCE was once manufactured still expose nearby residential areas to high levels of the chemical, increasing the likelihood of individuals developing Parkinson’s disease and other adverse health effects. Researchers from the Barrow Neurological Institute in Phoenix, Arizona examined the link between TCE-contaminated sites and the risk of Parkinson’s disease in nearby residents. Led by Dr. Brittany Krzyzanowski, the team examined data from 221,000 Medicare beneficiaries with Parkinson’s disease, comparing them with more than 1.1 million control patients. Krzyzanowski’s team used census tract residential data and compared that to the EPA’s National Air Toxics Assessment program to calculate exposure to ambient TCE. They mapped ambient TCE patterns for the 10-mile radius around the top three TCE emitting facilities from the EPA’s Toxic Release Inventory in 2002. The data collected indicates people who had higher exposure to TCE had an increased risk of developing Parkinson’s disease. Among the people with the highest exposure, the risk of Parkinson’s disease was 10% higher after 14 years when compared to those with the lowest exposure. Researchers said the risk of Parkinson’s disease was dose-dependent, meaning the higher the concentration of ambient TCE the higher the likelihood a person had Parkinson’s. Such correlations are considered strong signs of a causal connection. “Despite limitations, our study provides new evidence of the potential importance of ambient TCE exposure on PD risk and identifies specific areas of the nation that may be targets for exposure remediation.” — Dr. Brittany Krzyzanowski, Ambient Trichloroethylene Exposure and Parkinson Disease Risk in Medicare Beneficiaries The risk of Parkinson’s was much higher around two out of three areas in the U.S., near the highest ambient TCE-emitting facilities. There are high levels of ambient TCE in the rust belt region of the U.S. as well as several other areas across the country. The data showed the likelihood of developing Parkinson’s disease decreased the farther a person lived from a TCE-contaminated facility. Even though TCE is banned, the researchers warned that these facilities still pose a health risk to nearby residents. Sign up for more health and legal news that could affect you or your family. Tags: Camp Lejeune, Cancer, Chemicals, Parkinsons Disease, TCE, Water Contamination Written By: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. More Camp Lejeune Stories Information About 2,500 Camp Lejeune Injury Claims May Influence Settlement Process October 27, 2025 Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025 U.S. Government Seeks Dismissal of Camp Lejeune Kidney Cancer Lawsuits September 15, 2025 0 Comments CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: today) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025) Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: yesterday) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025) Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 4 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)
Court Urged To Press Forward With Camp Lejeune Lawsuit Deadlines During Government Shutdown October 6, 2025
Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: today) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025)
Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: yesterday) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)
Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 4 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)